Anika Therapeutics Inc. (ANIK)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

32 WIGGINS AVENUE BEDFORD, MA 01730

Anika Therapeutics Inc. develops, manufactures and commercializes therapeutic products and devices intended to promote the protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid, a naturally occurring, biocompatible polymer found throughout the body.

Data as of 2020-09-12
Market Cap518.002 Million Shares Outstanding14.207 Million Avg 30-day Volume104.5 Thousand
P/E Ratio47.5 Dividend Yield EPS0.77
Price/Sales4.126 Price cash flow ratio19.0 Price free cash flow ratio-7.7
Book Value20.3 Price to Tangible Book3.28 Alpha-0.0
Short Interest Ratio % Short Interest to Float R-squared0.13965
BETA1.11375 52-week High/Low75.715 / 22.01 Stddev0.127343
View SEC Filings from ANIK instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 1 (0.07%) 0 (0.0%)
Funds Holding: 156 162 -3.7% 41 (2.67%) 45 (2.88%) -8.89%
13F shares: 13.808 Million 13.069 Million 5.66% 3.945 Million 3.567 Million 10.58%
% Ownership 97.2228 92.2391 5.4% 27.7749 25.1771 10.32%
New Positions: 17 19 -10.53% 3 10 -70.0%
Increased Positions 54 55 -1.82% 15 13 15.38%
Closed Positions 22 44 -50.0% 7 17 -58.82%
Reduced Positions 60 59 1.69% 19 19 0.0%
Total Calls 568.726 Thousand 59.933 Thousand 848.94% 216.9 Thousand 32.7 Thousand 563.3%
Total Puts 57 Thousand 84.6 Thousand -32.62% 37.5 Thousand 20.1 Thousand 86.57%
PUT/CALL Ratio 0.1 1.41 -92.91% 0.17 0.61 -72.13%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ANIK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ANIK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RICHARD STEPHEN

  • Director
0 2020-09-03 2

HENNEMAN JOHN B III

  • Director
0 2020-09-03 2

LEVITZ MICHAEL L EVP, CFO, TREASURER

  • Officer
0 2020-08-10 2

LOEROP JAMES EVP BUSINESS DEVELOPMENT

  • Officer
1,756 2020-07-08 2

BLANCHARD CHERYL R PRESIDENT, CEO, DIRECTOR

  • Officer
  • Director
9,903 2020-04-26 2

COLLERAN DAVID EVP, GENERAL COUNSEL, CORP SEC

  • Officer
0 2020-03-04 2

THOMPSON JEFFERY S

  • Director
10,949 2020-02-25 1

BOWER JOSEPH L.

  • Director
17,117 2020-02-25 2

LAND RAYMOND J

  • Director
13,399 2020-02-25 1

LARSEN GLENN R.

  • Director
11,697 2020-02-25 1

FINNERTY THOMAS CHIEF HUMAN RESOURCES OFFICER

  • Officer
8,247 2020-02-25 2

VOGT SUSAN L N

  • Director
11,652 2020-02-25 1

CHEUNG SYLVIA CHIEF FINANCIAL OFFICER

  • Officer
47,162 2020-02-04 3

DARLING JOSEPH G PRESIDENT AND CEO; DIRECTOR

  • Officer
  • Director
20,289 2019-07-27 0

AHN EDWARD S. CHIEF TECH & STRATEGY OFFICER

  • Officer
0 2019-02-26 0

HAGUE RICHARD CHIEF COMMERCIAL OFFICER

  • Officer
0 2019-02-26 0

SHERWOOD CHARLES H CEO AND DIRECTOR

  • Officer
  • Director
0 2018-03-02 0

WHEELER STEVE E

  • Director
34,594 2018-01-24 0

ALEXANDER DANA M. CHIEF OPERATIONS OFFICER

  • Officer
0 2017-01-27 0

MASCIOLI STEPHEN R. CHIEF MEDICAL OFFICER

  • Officer
0 2016-04-04 0

MORAN JOHN C

  • Director
14,803 2015-08-07 0

LUPPINO FRANCESCO J CHIEF OPERATING OFFICER

  • Officer
0 2015-02-03 0

BARNETT CAROL A CHIEF COMMERCIAL OFFICER

  • Officer
6,100 2014-01-27 0

SHEETS JOHN W JR CHIEF SCIENTIFIC OFFICER

  • Officer
0 2013-10-02 0

FIDIA FARMACEUTICI S.P.A.

  • 10% Owner
No longer subject to file 2013-08-06 0

FIDIA FARMACEUTICI S.P.A.

P&R S.P.A.

FIORE HOLDING S.R.L.

  • 10% Owner
No longer subject to file 2013-08-06 0

QUINLAN KEVIN W CHIEF FINANCIAL OFFICER

  • Officer
27,112 2013-03-27 0

DAVIDSON EUGENE A

  • Director
71,763 2011-01-18 0

MRACHEK WILLIAM VICE PRESIDENT, HUMAN RESOURCE

  • Officer
0 2011-01-18 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RICHARD STEPHEN - Director

2020-09-08 18:14:13 -0400 2020-09-03 A 9,310 a 9,310 direct -0.4351 0.8431 0.8431 6 -2.774 5

HENNEMAN JOHN B III - Director

2020-09-08 18:12:20 -0400 2020-09-03 A 9,310 a 9,310 direct -0.4351 0.8431 0.8431 6 -2.774 5

LEVITZ MICHAEL L - Officer EVP, CFO, TREASURER

2020-08-12 16:10:18 -0400 2020-08-10 A 11,577 a 11,577 direct

LEVITZ MICHAEL L - Officer EVP, CFO, TREASURER

2020-08-12 16:10:18 -0400 2020-08-10 A 57,145 a 57,145 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments